Ginkgo biloba and Memory: An Overview

References

• Allain, H., Lieury, A., Reymann, J.M., Martinet, J.P, Trebon, P., Decombe, R., Bentue-Ferrer, D. and Gandon, J.M. (1990) Development of memory improving drugs. Annales de Medecine Interne 141 (suppl.), 19–25.
   PubMedGoogle Scholar
• Allain, H., Raoul, P, Lieury, A., LeCoz, F., Gandon, J.M. and d'Arbigny, P. (1993) Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clinical Therapeutics 15, 549–558.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th ed.) (Washington, D.C.: American Psychiatric Association).
   Google Scholar
• Amri, H., Ogwuegbu, S.O., Boujrad, N., Drieu, K. and Papadopoulos, V. (1996) In vivo regulation of peripheraltype benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract Egb 761 and isolated Ginkgolides. Endocrinology 137, 5707–5718.
   PubMed Web of Science ®Google Scholar
• Arenz, A., Klein, M., Fiehe, K., GroB, J., Drewke, C., Hemscheidt, T. and Leistner, E. (1996) Occurrence of neurotoxic 4′-O-methylpyridoxine in Ginkgo biloba leaves, Ginkgo medications and Japanese Ginkgo food. Planta Medica 62, 548–551.
   PubMed Web of Science ®Google Scholar
• Barbee, J.G. (1993) Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. Journal of Clinical Psychiatry 54 (suppl.), 86–101.
   PubMedGoogle Scholar
• Barkats, M., Venault, P., Christen, Y. and Cohen-Salmon, C. (1995) Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sciences 56, 213–222.
   PubMed Web of Science ®Google Scholar
• Blumenthal, M. (1995) Canada approves Ginkgo for food use. HerbalGram 34, 21.
   Google Scholar
• Clostre, F. (1986) From the body to the cell membrane: the different levels of pharmacological action of Ginkgo biloba extract. Press Medicale 15, 1529–1538.
   PubMedGoogle Scholar
• De Feudis, F.V. (ed.) (1991) Ginkgo-Biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications. (Amsterdam: Elsevier).
   Google Scholar
• Del Tredici, P. (1991) Ginkgos and people—a thousand years of interaction. Arnoldia 51, 2–15.
   Google Scholar
• Del Tredici, P. (1993) Hibaku trees of Hiroshima. Arnoldia 53, 24–29.
   Google Scholar
• Drieu, K. (1986) Preparation and definition of Ginkgo biloba extract. Press Medicale 15, 1455–1457.
   PubMed Web of Science ®Google Scholar
• Drug Evaluation, Monographs (1997) Ginkgo. Micromedex Inc. 93.
   Google Scholar
• Eisai, Inc. and Pfizer, Inc. (1997). Once-a-day Aricept (donezepil HCL) (Teaneck, New Jersey and New York, New York: Eisai and Pfizer).
   Google Scholar
• Famighetti, R. (ed.) (1997) The World Almanac and Book of Facts (Mahwah, New Jersey: World Almanac Books), p. 387.
   Google Scholar
• Foster, S. (1996) Ginkgo, Ginkgo biloba (Austin, Texas: American Botanical Council Botanical Series No. 304).
   Google Scholar
• Fricker, J. (1997) From mechanisms to drugs in Alzheimer's disease (news). Lancet 349, 480.
   PubMed Web of Science ®Google Scholar
• Frostl, W. and Maitre, L. (1989) The families of cognitive enhancers. Pharmacopsychiatry 22 (suppl. 2), 54–100.
   PubMed Web of Science ®Google Scholar
• Grassel, E. (1992) Effect of Ginkgo-biloba extract on mental performance. Fortschritte der Medizen 110, 73–76.
   PubMedGoogle Scholar
• Gsell, W., Reichert, N., Youdim, M.B.H. and Riederer, P. (1995) Interaction of neuroprotective substances with human brain superoxide dismutase. An in vitro study. Journal of Neural Transmission (suppl.) 45, 271–279.
   PubMedGoogle Scholar
• Haase, J., Halama, P. and Horr, R. (1996) Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type. Zeitschrift fur Gerontologie und Geriatrie 29, 302–309.
   PubMed Web of Science ®Google Scholar
• Hopfenmuller, W. (1994) Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age. Arzneimittel-Forschung 44, 1005–1013.
   PubMedGoogle Scholar
• Hoyer, S. (1995) Possibilities and limits of therapy of cognitive disorders in the elderly. Zeitschrift fur Gerontologie und Geriatrie 28, 257–262.
   Google Scholar
• Hsieh, L. (1992) Origin and distribution of Ginkgo biloba. The Forestry Chronicle 68, 612–613.
   Web of Science ®Google Scholar
• Huguet, F., Drieu, K. and Piriou, A. (1994) Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EHb 761). Journal of Pharmacy and Pharmacology 46, 316–318.
   PubMed Web of Science ®Google Scholar
• Huh, H. and Staba, E.J. (1992) The botany and chemistry of Ginkgo biloba L. Journal of Herbs, Spices and Medicinal Plants 1(1/2), 91–124.
   Google Scholar
• Ibata, K., Mizuno, M., Takigawa, T. and Tanaka, Y. (1983) Long-chain betulaprenol-type polyprenols from the leaves of Ginkgo biloba. Journal of Biochemistry 213, 305–311.
   Google Scholar
• Itil, T. and Martorano, D. (1995) Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmacology Bulletin 31, 147–158.
   PubMedGoogle Scholar
• Jaggy, H. and Koch, E. (1997) Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie 52, 735–738.
   PubMed Web of Science ®Google Scholar
• Kanowski, S., Hermann, W.M., Stephan, K., Wierich, W. and Horr, R. (1996) Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primay degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29, 47–56.
   PubMed Web of Science ®Google Scholar
• Kaplan, H.I., Sadock, B.J. and Grebb, J.A. (1994a) Biological therapies. In: Synopsis of Psychiatry (7th ed.) (Baltimore, Maryland: Williams & Wilkins), pp. 985–987.
   Google Scholar
• Kaplan, H.I., Sadock, B.J. and Grebb, J.A. (1994b) Geriatric psychiatry. In: Synopsis of Psychiatry (7th ed.) (Baltimore, Maryland: Williams & Wilkins), pp. 1155–1170.
   Google Scholar
• Kelly, C.A., Harvey, R.J. and Cayton, H. (1997) Drug treatment for Alzheimer's disease, (editorial) British Medical Journal 314, 693–694.
   PubMed Web of Science ®Google Scholar
• Keltner, N.L. (1994) Tacrine: a pharmacological approach to Alzheimer's disease. Journal of Psychosocial Nursing and Mental Health Services 32, 37–39.
   PubMedGoogle Scholar
• Kleijnen, J. and Knipschild, P. (1992a) Ginkgo biloba for cerebral insufficiency. British Journal of Clinical Pharmacology 34, 352–358.
   PubMed Web of Science ®Google Scholar
• Kleijnen, J. and Knipschild, P. (1992b) Ginkgo biloba. Lancet 340, 1136–1139.
   PubMed Web of Science ®Google Scholar
• Kose, K. and Dogan, P. (1995) Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761). 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid soluble antioxidants. Journal of International Medical Research 23, 1–18.
   PubMed Web of Science ®Google Scholar
• Krochmal, C. and Krochmal, A. (1993) Ginkgo biloba Maidenhair tree. Arbor Age 13, 34.
   Google Scholar
• Kumar, V., Goldstein, M.Z. and Pudugramam, M.D. (1996) Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease. Psychiatric Services 47, 249–253.
   PubMed Web of Science ®Google Scholar
• Maitra, I., Marcocci, L., Droy-Lefaix, M.T. and Packer, L. (1995) Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochemical Pharmacology 49, 1649–1655.
   PubMed Web of Science ®Google Scholar
• Major, R.T. (1967) The Ginkgo, the most ancient living tree. Science 157, 1270–1273.
   PubMed Web of Science ®Google Scholar
• Marcocci, L., Maguire, J.J., Droy-Lefaix, M.T. and Packer, L. (1994) The nitric oxide-scavenging properties of Ginkgobiloba extract EGb 761. Biochemical and Biophysical Research Communications 201, 748–755.
   PubMed Web of Science ®Google Scholar
• Marx, J. (1996) Searching for drugs that combat Alzheimer's. Science 273, 50–53.
   PubMed Web of Science ®Google Scholar
• Michel, P.F. and Hosford, D. (1988) Ginkgo biloba: from “living fossil” to modern therapeutic agent. In: Braquet, P. (ed.), Ginkgolides-Chemistry, Biology, Pharmacology, and Clinical Perspectives (vol. 1) (Barcelona: J.R. Prous), pp. 1–8.
   Google Scholar
• Morrison-Bogorad, M., Phelps, C. and Buckholtz, N. (1997) Alzheimer disease research comes of age (editorial). Journal of the American Medical Association 277, 837–840.
   Web of Science ®Google Scholar
• Noda, Y., Anzai, K., Mori, A., Kohno, M., Shinme, M. and Packer, L. (1997) Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochemistry and Molecular Biology International 42, 35–44.
   PubMedGoogle Scholar
• Norberg, A. (1996) Pharmacological treatment of cognitive dysfunction in dementia disorders. Acta Neurologica Scandinavia. Supplementum. 168, 87–92.
   PubMedGoogle Scholar
• Odawara, M., Tamaoka, A. and Yamashita, K. (1997) Ginkgo biloba. (Letter to editor) Neurology 48, 789.
   PubMed Web of Science ®Google Scholar
• Pepeu, G. (1994) Memory disorders: novel treatments, clinical perspective. Life Sciences 55, 2189–2194.
   PubMed Web of Science ®Google Scholar
• Pietri, S., Maurelli, E., Drieu, K. and Culcas, M. (1997) Cardioprotective and antioxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). Journal of Molecular and Cellular Cardiology 29, 733–742.
   PubMed Web of Science ®Google Scholar
• Racagni, G., Brunello, N. and Paoletti, R. (1986) Neuromediator changes during cerebral aging. The effect of Ginkgo biloba extract. Presse Medicate 15, 1488–1490.
   PubMedGoogle Scholar
• Rai, G.S., Shovlin, C. and Wesnes, K.A. (1991) A double-blind, placebo-controlled study of Ginkgo-biloba extract (‘tanakan’) in elderly outpatients with mild to moderate memory impairment. Current Medical Research and Opinion 12, 350–355.
   PubMed Web of Science ®Google Scholar
• Ramassamy, C., Naudin, B., Christen, Y., Clostre, F. and Costenin, J. (1992) Prevention by Ginkgo biloba extract (EGb 761) and trolox C of the decrease in synaptosomal dopamine or serotonin uptake following incubation. Biochemical Pharmacology 44, 2395–2401.
   PubMed Web of Science ®Google Scholar
• Rapin, J.R., Lamproglou, I., Drieu, K. and De Feudis, F.V. (1994) Demonstration of the “anti-stress” activity of an extract of Ginkgo biloba (EGb 761) using discrimination learning tool. General Pharmacology 25, 1009–1016.
   PubMedGoogle Scholar
• Reisecker, F. (1996) Therapy approaches in cerebral cognitive deficits—neuropsychiatric aspects. Wien Med Wochenschr 146, 546–548.
   PubMedGoogle Scholar
• Reynolds, J.E.F. (ed.) (1993) Martindale The Extra Pharmacopoeia (13th ed.) (London: The Pharmaceutical Press).
   Google Scholar
• Riedel, W.J. and Jolles, J. (1996) Cognitive enhancers in age-related cognitive decline. Drugs and Aging 8, 245–274.
   PubMed Web of Science ®Google Scholar
• Rogers, S.L., Friedhoff, L.T., and The Donepezil Study Group (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia 7, 293–303.
   PubMedGoogle Scholar
• Roncin, J.P., Schwartz, F. and D'Arbigny, P. (1996) EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviation Space and Environmental Medicine 67, 445–452.
   PubMed Web of Science ®Google Scholar
• Rosen, W.G., Mohs, R.C. and Davis, K.L. (1984) A new rating scale for Alzheimer's disease. American Journal of Psychiatry 141, 1356–1364.
   PubMed Web of Science ®Google Scholar
• Rosenblatt, M. and Mindel, J. (1997) Spontaneous hyphema associated with ingestion of Ginkgo biloba extract, (letter to editor) New England Journal of Medicine 336, 1108.
   PubMed Web of Science ®Google Scholar
• Rowin, J. and Lewis, S.L. (1996) Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion, (clinical/scientific note) Neurology 46, 1775–1776.
   PubMed Web of Science ®Google Scholar
• Schmid, W. (1997) Ginkgo thrives, (letter to editor) Nature 386, 755.
   PubMed Web of Science ®Google Scholar
• Schneider, L.S. (1996) New therapeutic approaches to Alzheimer's disease. Journal of Clinical Psychiatry 57, 30–36.
   PubMed Web of Science ®Google Scholar
• Scholtyssek, H., Damerau, W., Wessel, R. and Schimke, I. (1997) Antioxidative activity of Ginkgolides against superoxide in an aprotic environment. Chemico-Biological Interactions 106, 183–190.
   PubMed Web of Science ®Google Scholar
• Semlitsch, H.V., Anderer, P., Saletu, B., Binder, G.A. and Decker, K.A. (1995) Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment. Pharmacopsychiatry 28, 134–142.
   PubMed Web of Science ®Google Scholar
• Skolnick, A.A. (1997) Old Chinese herbal medication used for fever yields possible new Alzheimer's disease therapy. Journal of the American Medical Association 277, 776.
   Web of Science ®Google Scholar
• Smith, P.F., Maclennan, K. and Darlington, C.L. (1996) The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). Journal of Ethnopharmacology 50, 131–139.
   PubMed Web of Science ®Google Scholar
• Stem, R.G., Mohs, R.C., Davidson, M., Schmeidler, J., Silverman, J., Kramer-Ginsberg, E., Searcey, T., Bierer, L. and Davis, K.L. (1994) A longtitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. American Journal of Psychiatry 151, 390–396.
   PubMed Web of Science ®Google Scholar
• Sticher, O. (1993) Quality of Ginkgo preparations. Planta Medica 59, 2–11.
   PubMed Web of Science ®Google Scholar
• Stoll, S., Scheuer, O., Pohl, O. and Muller, W.E. (1996) Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 29, 144–149.
   PubMed Web of Science ®Google Scholar
• Stoppe, G., Sandholzer, H., Staedt, J., Winter, S., Kiefer, J. and Ruther, E. (1996) Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?—Results of a representative survey in lower Saxony, Germany. Pharmacopsychiatry 29, 150–155.
   PubMed Web of Science ®Google Scholar
• Subhan, Z. and Hindmarch, I. (1984) The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. International Journal of Clinical Pharmacology Research 4, 89–93.
   PubMedGoogle Scholar
• Warburton, D.M. (1986) Clinical psychopharmacology of Ginkgo biloba extract. Presse Medicale 15, 1595–1604.
   PubMed Web of Science ®Google Scholar
• White, H.L., Scates, P.W. and Cooper, B.R. (1996) Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sciences 58, 1315–1321.
   PubMed Web of Science ®Google Scholar
• Yan, L.J., Droy-Lefaix, M.T. and Packer, L. (1995) Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochemical and Biophysical Research Communications 212, 360–366.
   PubMed Web of Science ®Google Scholar
• Z'Brun, A. (1995) Ginkgo—myth and reality. Schweizerische Rundschau fur Medizin Praxis 84, 1–6.
   PubMedGoogle Scholar